510(k) Report

PMA · Approved

Approved

Nevisense

P150046PMAApproved Jun 28, 2017569-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Scibase AB · ONV Electrical Impedance Spectrometer

Approved on Jun 28, 2017 through premarket approval, which rests on the device’s own clinical evidence after a 569-day review.

Decided
Jun 28, 2017
Review
569 days
Class
Class III
Product code
ONV
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P150046 has 6 supplements since 2018: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2018: 22019: 12020: 12025: 12026: 1
2018high 2 (2018) · low 0 (2021)2026
View FIG. 1 as a table
YearSupplements approved
20182
20191
20201
20251
20261
FIG. 1 — Supplements to P150046, 2018–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ONV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All ONV devices

ONV Electrical Impedance Spectrometer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · ONV

1in 2025

2017: 12018: 22019: 12020: 12025: 12026 (partial year): 1
2007high 2 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ONV

Too few ONV 510(k)s in any year since 2007 to give a median.

Recalls per year · ONV

No recall names ONV since 2007.

Adverse event reports per year · ONV

1in 2019

2019: 1
2007high 1 (2019) · low 0 (2007)2025

MAUDE reports naming product code ONV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20182—00
20191—01
20201—00
20210—00
20220—00
20230—00
20240—00
20251—00
20261—0—
Cite this page

510(k) Report. “P150046: Nevisense.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P150046

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026